Respiratory Device Market to Expand at 9.90% CAGR Through 2034

 

The global respiratory device market is entering a transformative decade, with projections indicating remarkable growth driven by technological innovation, increasing respiratory illness prevalence, and supportive healthcare policies. Valued at USD 26,873.7 million in 2024, the market is expected to more than double, surpassing USD 69,072.5 million by 2034. This reflects a robust CAGR of 9.90% during the forecast period.

A key driver of this expansion is the rising demand for effective treatments for chronic obstructive pulmonary disease (COPD) and asthma, particularly through combination therapies. The COVID-19 pandemic further underscored the critical role of respiratory devices in both patient care and infection control, reshaping healthcare priorities globally. With governments and private entities channeling significant investments into healthcare, the adoption of these devices has accelerated across developed and emerging economies.

Positive Airway Pressure Devices Retain their Dominance in the Healthcare Sector

Among various respiratory products, positive airway pressure (PAP) devices remain at the forefront, holding an estimated market share of 31.30% in 2024. Widely recognized for their effectiveness in managing sleep apnea and other respiratory disorders, these devices have become indispensable in hospitals and homecare settings.

The affordability and accessibility of PAP devices have contributed significantly to their popularity, particularly among patients seeking to improve quality of life while reducing risks associated with untreated respiratory issues. Beyond medical benefits, these devices also help in reducing fatigue and improving productivity, making them especially relevant for working professionals and frequent travelers. This strong demand underscores their sustained dominance in the market.

Click Here for More Information:- https://www.futuremarketinsights.com/reports/respiratory-devices-market

Hospitals Consume Almost Half Respiratory Devices

Hospitals remain the largest end-user segment for respiratory devices, accounting for 40.70% of total demand in 2024. Their role is crucial in handling severe cases such as pneumonia, acute respiratory distress syndrome (ARDS), and COPD.

The increased dependence on respiratory aids in hospitals is largely a result of the pandemic, which highlighted the necessity for advanced ventilators and airway management systems. Moreover, hospitals continue to rely heavily on these devices during surgical procedures, ensuring safe and effective patient care. With global healthcare facilities expanding capacity and modernizing infrastructure, hospital-based demand is expected to remain resilient throughout the decade.

Mergers and Acquisitions to Shape the Future of Germany’s Respiratory Device Market

Germany is emerging as one of the most dynamic markets, with a projected CAGR of 12.10% through 2034. The nation’s focus on sophisticated, AI-driven, and connected medical devices has spurred a wave of mergers, partnerships, and acquisitions.

A notable example is ResMed’s 2022 acquisition of Medifox Dan, a German software firm specializing in healthcare solutions. Such collaborations are equipping manufacturers with advanced capabilities in data-driven care, strengthening their competitive edge. With Germany’s strong industrial base and innovation-driven approach, the country is poised to remain a hotspot for respiratory device advancements.

Sophisticated Medical Infrastructure Supports the Adoption of Respiratory Aids in France

France is set to achieve a CAGR of 11.90% during the forecast period. Its advanced medical infrastructure and global reputation as a healthcare hub create a strong foundation for respiratory device adoption.

The country’s hospitals, clinics, and ambulatory surgical centers are early adopters of respiratory technologies, driven by both patient demand and institutional readiness. Millions of patients travel annually to France for treatment, further reinforcing demand for state-of-the-art respiratory solutions. This, combined with supportive regulatory frameworks, positions France as a leading European market for respiratory devices.

Government Initiatives to Benefit India’s Respiratory Device Market

India’s respiratory device market is projected to expand at a CAGR of 11.40% through 2034, supported by government-led healthcare inclusion programs. Initiatives aimed at providing affordable healthcare access to large sections of the population are driving hospitals and clinics to adopt advanced respiratory aids.

The rapid improvement of healthcare infrastructure post-pandemic has created favorable conditions for device deployment. As the nation continues to prioritize accessible healthcare, manufacturers are tapping into India’s growing demand with localized, cost-effective solutions.

Made-in-Canada Devices to Help Elderly Patients Breathe

Canada’s respiratory device market is expected to grow at a CAGR of 10.30% during the decade. The country benefits from strong collaboration between academic institutions and the medical industry, leading to innovative product development.

One notable innovation was the “Canada Hood,” developed during the COVID-19 pandemic to aid critically ill patients. With an aging population and high prevalence of chronic respiratory diseases, Canada is expected to sustain steady demand for homegrown respiratory technologies designed for patient comfort and reliability.

Mexico’s Respiratory Device Market to Profit amidst Rising Smog

Mexico, projected to grow at a CAGR of 10.10%, is witnessing increasing demand for respiratory devices due to environmental factors such as smog and pollution. Agricultural practices involving crop residue burning contribute to respiratory challenges, fueling the need for medical interventions.

This environmental reality, combined with growing awareness of respiratory health, is expected to drive adoption of respiratory aids across hospitals and households alike.

Get Sample Report: - https://www.futuremarketinsights.com/reports/sample/rep-gb-794

Competitive Landscape

The global respiratory device market remains highly competitive, with major players such as ResMed Inc., Medtronic plc., Koninklijke Philips N.V., Fisher & Paykel Healthcare, and Drägerwerk AG leading innovation. Companies are increasingly investing in cost-effective, patient-centric solutions to address both developed and developing markets.

Recent developments highlight this momentum:

• ResMed’s AirCurve 11 series launched in February 2024, offering enhanced bilevel PAP therapy.
• University of Canterbury researchers introduced BOB, a data-driven respiratory monitoring tool.
• Dräger received Frost & Sullivan’s Company of the Year Award in February 2024.
• Clario’s acquisition of ArtiQ in April 2024 expanded AI integration in respiratory trials.
• SunMed’s acquisition of Avanos Medical’s respiratory health business in 2023 broadened its portfolio.

These strategic moves underscore the sector’s dynamism, where product innovation and digital integration are shaping future growth.

Key Coverage in the Respiratory Device Market

• Demand Analysis of Respiratory Devices for COPD
• Overview of Airway Devices in Anesthesia
• Market Insights on Breathing Aids
• Industrial Analysis of Breathing Aids for Sleep Apnea
• Emerging Trends in the Respiratory Device Market

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:     

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube